Nrf3 promotes the proliferation and migration of triple ‑negative breast cancer by activating PI3K/AKT/mTOR and epithelial‑mesenchymal transition

In conclusion, Nrf3 enhances cellular proliferation and migration by activating PI3K/AKT/mTOR signaling pathways, highlighting a novel therapeutic target for TNBC.PMID:37720674 | PMC:PMC10502936 | DOI:10.3892/ol.2023.14030

Source: Oncology Letters - September 18, 2023 Category: Cancer & Oncology Authors: Wan-Meng Chen Qing-Yong Hu Wei Hou Meng-Wei Chen Ya-Hui Chen Jian-Cai Tang Source Type: research